Evaxion A/s (EVAX) — Institutional Investor Activity (Q2 2026)

EVAX ranks #8384 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

EVAX is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

20 institutions disclose a position in EVAX, but none treat it as a major bet — even Merck & Co., Inc., its most concentrated holder, allocates just 0.7% of its own portfolio to it.

Ikarian Capital, LLC has trimmed its EVAX position for two straight quarters, cutting it by $124.7K while still holding $231.6K.

EVAX is down 4.4% today, but institutions show net buying of $3.9M this quarter — a divergence between today's price move and the underlying institutional flow.

EVAX reported a net loss of $7.7M in its latest fiscal year.

• Not yet profitable — net loss of $7.7M in the latest fiscal year
• Revenue grew 125.1% year over year
• Net income improved year over year, from -$10.6M to -$7.7M
• Operating cash flow was negative, using $6.6M in cash
• Current ratio of 5.85x — enough short-term assets to cover short-term liabilities